Log in

Aethlon Medical Stock Forecast, Price & News

-0.03 (-1.67 %)
(As of 12/4/2020 12:00 AM ET)
Today's Range
Now: $1.77
50-Day Range
MA: $1.56
52-Week Range
Now: $1.77
Volume229,146 shs
Average Volume1.51 million shs
Market Capitalization$21.40 million
P/E RatioN/A
Dividend YieldN/A
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.
Aethlon Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:AEMD



Sales & Book Value

Annual Sales$650,000.00
Book Value$1.12 per share


Net Income$-6,390,000.00


Market Cap$21.40 million
Next Earnings Date2/8/2021 (Estimated)
OptionableNot Optionable
-0.03 (-1.67 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

How has Aethlon Medical's stock been impacted by COVID-19?

Aethlon Medical's stock was trading at $1.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AEMD stock has decreased by 11.1% and is now trading at $1.77.
View which stocks have been most impacted by COVID-19

What stocks does MarketBeat like better than Aethlon Medical?

Wall Street analysts have given Aethlon Medical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aethlon Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Aethlon Medical's next earnings date?

Aethlon Medical is scheduled to release its next quarterly earnings announcement on Monday, February 8th 2021.
View our earnings forecast for Aethlon Medical

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) announced its earnings results on Monday, November, 2nd. The medical equipment provider reported ($0.15) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.12) by $0.03.
View Aethlon Medical's earnings history

Are investors shorting Aethlon Medical?

Aethlon Medical saw a decrease in short interest in the month of October. As of October 30th, there was short interest totaling 576,800 shares, a decrease of 49.8% from the October 15th total of 1,150,000 shares. Based on an average trading volume of 574,100 shares, the days-to-cover ratio is currently 1.0 days. Currently, 4.9% of the company's shares are sold short.
View Aethlon Medical's Short Interest

Who are some of Aethlon Medical's key competitors?

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the following people:
  • Dr. Timothy C. Rodell, CEO & Director (Age 69, Pay $595k)
  • Mr. James B. Frakes, CFO, Sr. VP of Fin. & Sec. (Age 63, Pay $354.75k)
  • Mr. Sunil Sawhney, Head of Clinical Studies
  • Dr. Richard H. Tullis, Consultant (Age 75)

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $1.77.

How big of a company is Aethlon Medical?

Aethlon Medical has a market capitalization of $21.40 million and generates $650,000.00 in revenue each year. The medical equipment provider earns $-6,390,000.00 in net income (profit) each year or ($1.87) on an earnings per share basis. Aethlon Medical employs 8 workers across the globe.

What is Aethlon Medical's official website?

The official website for Aethlon Medical is www.aethlonmedical.com.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]

This page was last updated on 12/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.